nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS2—pancreatic cancer	0.564	1	CbGaD
Diflunisal—ALB—Erlotinib—pancreatic cancer	0.0522	0.361	CbGbCtD
Diflunisal—ALB—Irinotecan—pancreatic cancer	0.0471	0.326	CbGbCtD
Diflunisal—ALB—Fluorouracil—pancreatic cancer	0.0452	0.313	CbGbCtD
Diflunisal—Niclosamide—STAT3—pancreatic cancer	0.00612	0.535	CrCbGaD
Diflunisal—Olsalazine—PPARG—pancreatic cancer	0.00146	0.128	CrCbGaD
Diflunisal—Mesalazine—PPARG—pancreatic cancer	0.00108	0.0941	CrCbGaD
Diflunisal—Olsalazine—PTGS2—pancreatic cancer	0.000616	0.0539	CrCbGaD
Diflunisal—Aminosalicylic Acid—PTGS2—pancreatic cancer	0.000579	0.0506	CrCbGaD
Diflunisal—Salsalate—PTGS2—pancreatic cancer	0.000524	0.0458	CrCbGaD
Diflunisal—Mesalazine—PTGS2—pancreatic cancer	0.000454	0.0397	CrCbGaD
Diflunisal—Oedema—Irinotecan—pancreatic cancer	0.00045	0.00183	CcSEcCtD
Diflunisal—Photosensitivity—Doxorubicin—pancreatic cancer	0.000449	0.00183	CcSEcCtD
Diflunisal—Chest pain—Fluorouracil—pancreatic cancer	0.000449	0.00183	CcSEcCtD
Diflunisal—Renal impairment—Epirubicin—pancreatic cancer	0.000448	0.00183	CcSEcCtD
Diflunisal—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000446	0.00182	CcSEcCtD
Diflunisal—Pruritus—Erlotinib—pancreatic cancer	0.000446	0.00182	CcSEcCtD
Diflunisal—Shock—Irinotecan—pancreatic cancer	0.000442	0.0018	CcSEcCtD
Diflunisal—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00044	0.0018	CcSEcCtD
Diflunisal—Oedema—Gemcitabine—pancreatic cancer	0.000438	0.00179	CcSEcCtD
Diflunisal—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000438	0.00179	CcSEcCtD
Diflunisal—Hepatitis—Docetaxel—pancreatic cancer	0.000437	0.00179	CcSEcCtD
Diflunisal—Diarrhoea—Tamoxifen—pancreatic cancer	0.000436	0.00178	CcSEcCtD
Diflunisal—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000435	0.00177	CcSEcCtD
Diflunisal—Confusional state—Fluorouracil—pancreatic cancer	0.000434	0.00177	CcSEcCtD
Diflunisal—Body temperature increased—Sunitinib—pancreatic cancer	0.000431	0.00176	CcSEcCtD
Diflunisal—Diarrhoea—Erlotinib—pancreatic cancer	0.000431	0.00176	CcSEcCtD
Diflunisal—Oedema—Fluorouracil—pancreatic cancer	0.000431	0.00176	CcSEcCtD
Diflunisal—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000431	0.00176	CcSEcCtD
Diflunisal—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000429	0.00175	CcSEcCtD
Diflunisal—Anorexia—Irinotecan—pancreatic cancer	0.000429	0.00175	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000426	0.00174	CcSEcCtD
Diflunisal—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000423	0.00173	CcSEcCtD
Diflunisal—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000422	0.00172	CcSEcCtD
Diflunisal—Visual impairment—Docetaxel—pancreatic cancer	0.000422	0.00172	CcSEcCtD
Diflunisal—Dizziness—Tamoxifen—pancreatic cancer	0.000421	0.00172	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000418	0.00171	CcSEcCtD
Diflunisal—Anorexia—Gemcitabine—pancreatic cancer	0.000417	0.0017	CcSEcCtD
Diflunisal—Dizziness—Erlotinib—pancreatic cancer	0.000417	0.0017	CcSEcCtD
Diflunisal—Renal impairment—Doxorubicin—pancreatic cancer	0.000415	0.00169	CcSEcCtD
Diflunisal—Erythema multiforme—Docetaxel—pancreatic cancer	0.000414	0.00169	CcSEcCtD
Diflunisal—Anorexia—Fluorouracil—pancreatic cancer	0.00041	0.00167	CcSEcCtD
Diflunisal—Insomnia—Irinotecan—pancreatic cancer	0.000407	0.00166	CcSEcCtD
Diflunisal—Flushing—Docetaxel—pancreatic cancer	0.000406	0.00166	CcSEcCtD
Diflunisal—Vomiting—Tamoxifen—pancreatic cancer	0.000405	0.00165	CcSEcCtD
Diflunisal—Paraesthesia—Irinotecan—pancreatic cancer	0.000404	0.00165	CcSEcCtD
Diflunisal—Hypersensitivity—Sunitinib—pancreatic cancer	0.000402	0.00164	CcSEcCtD
Diflunisal—Rash—Tamoxifen—pancreatic cancer	0.000402	0.00164	CcSEcCtD
Diflunisal—Dermatitis—Tamoxifen—pancreatic cancer	0.000401	0.00164	CcSEcCtD
Diflunisal—Vomiting—Erlotinib—pancreatic cancer	0.000401	0.00164	CcSEcCtD
Diflunisal—Dyspnoea—Irinotecan—pancreatic cancer	0.000401	0.00164	CcSEcCtD
Diflunisal—Somnolence—Irinotecan—pancreatic cancer	0.0004	0.00163	CcSEcCtD
Diflunisal—Headache—Tamoxifen—pancreatic cancer	0.000399	0.00163	CcSEcCtD
Diflunisal—Rash—Erlotinib—pancreatic cancer	0.000397	0.00162	CcSEcCtD
Diflunisal—Dermatitis—Erlotinib—pancreatic cancer	0.000397	0.00162	CcSEcCtD
Diflunisal—Insomnia—Gemcitabine—pancreatic cancer	0.000396	0.00162	CcSEcCtD
Diflunisal—Dyspepsia—Irinotecan—pancreatic cancer	0.000396	0.00161	CcSEcCtD
Diflunisal—Headache—Erlotinib—pancreatic cancer	0.000395	0.00161	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000395	0.00161	CcSEcCtD
Diflunisal—Paraesthesia—Gemcitabine—pancreatic cancer	0.000393	0.0016	CcSEcCtD
Diflunisal—Asthenia—Sunitinib—pancreatic cancer	0.000392	0.0016	CcSEcCtD
Diflunisal—Decreased appetite—Irinotecan—pancreatic cancer	0.000391	0.00159	CcSEcCtD
Diflunisal—Dyspnoea—Gemcitabine—pancreatic cancer	0.00039	0.00159	CcSEcCtD
Diflunisal—Insomnia—Fluorouracil—pancreatic cancer	0.000389	0.00159	CcSEcCtD
Diflunisal—Somnolence—Gemcitabine—pancreatic cancer	0.000389	0.00159	CcSEcCtD
Diflunisal—Fatigue—Irinotecan—pancreatic cancer	0.000388	0.00158	CcSEcCtD
Diflunisal—Paraesthesia—Fluorouracil—pancreatic cancer	0.000387	0.00158	CcSEcCtD
Diflunisal—Pruritus—Sunitinib—pancreatic cancer	0.000386	0.00158	CcSEcCtD
Diflunisal—Constipation—Irinotecan—pancreatic cancer	0.000384	0.00157	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000384	0.00157	CcSEcCtD
Diflunisal—Dyspnoea—Fluorouracil—pancreatic cancer	0.000384	0.00157	CcSEcCtD
Diflunisal—Somnolence—Fluorouracil—pancreatic cancer	0.000383	0.00156	CcSEcCtD
Diflunisal—Decreased appetite—Gemcitabine—pancreatic cancer	0.000381	0.00155	CcSEcCtD
Diflunisal—Dyspepsia—Fluorouracil—pancreatic cancer	0.000379	0.00155	CcSEcCtD
Diflunisal—Nausea—Tamoxifen—pancreatic cancer	0.000378	0.00154	CcSEcCtD
Diflunisal—Fatigue—Gemcitabine—pancreatic cancer	0.000378	0.00154	CcSEcCtD
Diflunisal—Gastritis—Epirubicin—pancreatic cancer	0.000377	0.00154	CcSEcCtD
Diflunisal—Constipation—Gemcitabine—pancreatic cancer	0.000374	0.00153	CcSEcCtD
Diflunisal—Nausea—Erlotinib—pancreatic cancer	0.000374	0.00153	CcSEcCtD
Diflunisal—Decreased appetite—Fluorouracil—pancreatic cancer	0.000374	0.00153	CcSEcCtD
Diflunisal—Diarrhoea—Sunitinib—pancreatic cancer	0.000373	0.00152	CcSEcCtD
Diflunisal—Feeling abnormal—Irinotecan—pancreatic cancer	0.00037	0.00151	CcSEcCtD
Diflunisal—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000368	0.0015	CcSEcCtD
Diflunisal—Muscle spasms—Docetaxel—pancreatic cancer	0.000366	0.00149	CcSEcCtD
Diflunisal—Dizziness—Sunitinib—pancreatic cancer	0.000361	0.00147	CcSEcCtD
Diflunisal—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000361	0.00147	CcSEcCtD
Diflunisal—Body temperature increased—Irinotecan—pancreatic cancer	0.000355	0.00145	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000355	0.00145	CcSEcCtD
Diflunisal—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000355	0.00145	CcSEcCtD
Diflunisal—Gastritis—Doxorubicin—pancreatic cancer	0.000349	0.00143	CcSEcCtD
Diflunisal—Vomiting—Sunitinib—pancreatic cancer	0.000347	0.00142	CcSEcCtD
Diflunisal—Body temperature increased—Gemcitabine—pancreatic cancer	0.000346	0.00141	CcSEcCtD
Diflunisal—Dysuria—Epirubicin—pancreatic cancer	0.000345	0.00141	CcSEcCtD
Diflunisal—Rash—Sunitinib—pancreatic cancer	0.000344	0.0014	CcSEcCtD
Diflunisal—Dermatitis—Sunitinib—pancreatic cancer	0.000344	0.0014	CcSEcCtD
Diflunisal—Urticaria—Fluorouracil—pancreatic cancer	0.000342	0.0014	CcSEcCtD
Diflunisal—Headache—Sunitinib—pancreatic cancer	0.000342	0.0014	CcSEcCtD
Diflunisal—Syncope—Docetaxel—pancreatic cancer	0.000341	0.00139	CcSEcCtD
Diflunisal—Body temperature increased—Fluorouracil—pancreatic cancer	0.00034	0.00139	CcSEcCtD
Diflunisal—Palpitations—Docetaxel—pancreatic cancer	0.000336	0.00137	CcSEcCtD
Diflunisal—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000336	0.00137	CcSEcCtD
Diflunisal—Loss of consciousness—Docetaxel—pancreatic cancer	0.000335	0.00137	CcSEcCtD
Diflunisal—Hypersensitivity—Irinotecan—pancreatic cancer	0.000331	0.00135	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000326	0.00133	CcSEcCtD
Diflunisal—Chest pain—Docetaxel—pancreatic cancer	0.000324	0.00132	CcSEcCtD
Diflunisal—Nausea—Sunitinib—pancreatic cancer	0.000324	0.00132	CcSEcCtD
Diflunisal—Renal failure—Epirubicin—pancreatic cancer	0.000323	0.00132	CcSEcCtD
Diflunisal—Asthenia—Irinotecan—pancreatic cancer	0.000323	0.00132	CcSEcCtD
Diflunisal—Salicylic acid—PTGS2—pancreatic cancer	0.000322	0.0282	CrCbGaD
Diflunisal—Stomatitis—Epirubicin—pancreatic cancer	0.00032	0.00131	CcSEcCtD
Diflunisal—Jaundice—Epirubicin—pancreatic cancer	0.00032	0.00131	CcSEcCtD
Diflunisal—Dysuria—Doxorubicin—pancreatic cancer	0.000319	0.0013	CcSEcCtD
Diflunisal—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000317	0.00129	CcSEcCtD
Diflunisal—Sweating—Epirubicin—pancreatic cancer	0.000315	0.00129	CcSEcCtD
Diflunisal—Asthenia—Gemcitabine—pancreatic cancer	0.000314	0.00128	CcSEcCtD
Diflunisal—Haematuria—Epirubicin—pancreatic cancer	0.000313	0.00128	CcSEcCtD
Diflunisal—Confusional state—Docetaxel—pancreatic cancer	0.000313	0.00128	CcSEcCtD
Diflunisal—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000311	0.00127	CcSEcCtD
Diflunisal—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000311	0.00127	CcSEcCtD
Diflunisal—Oedema—Docetaxel—pancreatic cancer	0.000311	0.00127	CcSEcCtD
Diflunisal—Pruritus—Gemcitabine—pancreatic cancer	0.00031	0.00126	CcSEcCtD
Diflunisal—Diarrhoea—Irinotecan—pancreatic cancer	0.000308	0.00126	CcSEcCtD
Diflunisal—Agranulocytosis—Epirubicin—pancreatic cancer	0.000307	0.00125	CcSEcCtD
Diflunisal—Shock—Docetaxel—pancreatic cancer	0.000306	0.00125	CcSEcCtD
Diflunisal—Pruritus—Fluorouracil—pancreatic cancer	0.000305	0.00124	CcSEcCtD
Diflunisal—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000304	0.00124	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000301	0.00123	CcSEcCtD
Diflunisal—Diarrhoea—Gemcitabine—pancreatic cancer	0.0003	0.00122	CcSEcCtD
Diflunisal—Renal failure—Doxorubicin—pancreatic cancer	0.000299	0.00122	CcSEcCtD
Diflunisal—Dizziness—Irinotecan—pancreatic cancer	0.000297	0.00121	CcSEcCtD
Diflunisal—Jaundice—Doxorubicin—pancreatic cancer	0.000296	0.00121	CcSEcCtD
Diflunisal—Stomatitis—Doxorubicin—pancreatic cancer	0.000296	0.00121	CcSEcCtD
Diflunisal—Anorexia—Docetaxel—pancreatic cancer	0.000296	0.00121	CcSEcCtD
Diflunisal—Hepatitis—Epirubicin—pancreatic cancer	0.000295	0.0012	CcSEcCtD
Diflunisal—Diarrhoea—Fluorouracil—pancreatic cancer	0.000295	0.0012	CcSEcCtD
Diflunisal—Sweating—Doxorubicin—pancreatic cancer	0.000292	0.00119	CcSEcCtD
Diflunisal—Haematuria—Doxorubicin—pancreatic cancer	0.00029	0.00118	CcSEcCtD
Diflunisal—Vomiting—Irinotecan—pancreatic cancer	0.000286	0.00117	CcSEcCtD
Diflunisal—Dizziness—Fluorouracil—pancreatic cancer	0.000285	0.00116	CcSEcCtD
Diflunisal—Visual impairment—Epirubicin—pancreatic cancer	0.000284	0.00116	CcSEcCtD
Diflunisal—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000284	0.00116	CcSEcCtD
Diflunisal—Rash—Irinotecan—pancreatic cancer	0.000283	0.00116	CcSEcCtD
Diflunisal—Dermatitis—Irinotecan—pancreatic cancer	0.000283	0.00116	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS2—pancreatic cancer	0.000282	0.0247	CrCbGaD
Diflunisal—Headache—Irinotecan—pancreatic cancer	0.000282	0.00115	CcSEcCtD
Diflunisal—Insomnia—Docetaxel—pancreatic cancer	0.000281	0.00115	CcSEcCtD
Diflunisal—Paraesthesia—Docetaxel—pancreatic cancer	0.000279	0.00114	CcSEcCtD
Diflunisal—Erythema multiforme—Epirubicin—pancreatic cancer	0.000279	0.00114	CcSEcCtD
Diflunisal—Vomiting—Gemcitabine—pancreatic cancer	0.000278	0.00114	CcSEcCtD
Diflunisal—Dyspnoea—Docetaxel—pancreatic cancer	0.000277	0.00113	CcSEcCtD
Diflunisal—Somnolence—Docetaxel—pancreatic cancer	0.000276	0.00113	CcSEcCtD
Diflunisal—Rash—Gemcitabine—pancreatic cancer	0.000276	0.00113	CcSEcCtD
Diflunisal—Dermatitis—Gemcitabine—pancreatic cancer	0.000276	0.00113	CcSEcCtD
Diflunisal—Tinnitus—Epirubicin—pancreatic cancer	0.000275	0.00112	CcSEcCtD
Diflunisal—Headache—Gemcitabine—pancreatic cancer	0.000274	0.00112	CcSEcCtD
Diflunisal—Flushing—Epirubicin—pancreatic cancer	0.000274	0.00112	CcSEcCtD
Diflunisal—Vomiting—Fluorouracil—pancreatic cancer	0.000274	0.00112	CcSEcCtD
Diflunisal—Dyspepsia—Docetaxel—pancreatic cancer	0.000274	0.00112	CcSEcCtD
Diflunisal—Hepatitis—Doxorubicin—pancreatic cancer	0.000273	0.00111	CcSEcCtD
Diflunisal—Rash—Fluorouracil—pancreatic cancer	0.000271	0.00111	CcSEcCtD
Diflunisal—Dermatitis—Fluorouracil—pancreatic cancer	0.000271	0.00111	CcSEcCtD
Diflunisal—Decreased appetite—Docetaxel—pancreatic cancer	0.00027	0.0011	CcSEcCtD
Diflunisal—Headache—Fluorouracil—pancreatic cancer	0.00027	0.0011	CcSEcCtD
Diflunisal—Fatigue—Docetaxel—pancreatic cancer	0.000268	0.00109	CcSEcCtD
Diflunisal—Nausea—Irinotecan—pancreatic cancer	0.000267	0.00109	CcSEcCtD
Diflunisal—Constipation—Docetaxel—pancreatic cancer	0.000266	0.00108	CcSEcCtD
Diflunisal—Visual impairment—Doxorubicin—pancreatic cancer	0.000263	0.00107	CcSEcCtD
Diflunisal—Nausea—Gemcitabine—pancreatic cancer	0.00026	0.00106	CcSEcCtD
Diflunisal—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000258	0.00105	CcSEcCtD
Diflunisal—Feeling abnormal—Docetaxel—pancreatic cancer	0.000256	0.00105	CcSEcCtD
Diflunisal—Nausea—Fluorouracil—pancreatic cancer	0.000256	0.00104	CcSEcCtD
Diflunisal—Tinnitus—Doxorubicin—pancreatic cancer	0.000255	0.00104	CcSEcCtD
Diflunisal—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000254	0.00104	CcSEcCtD
Diflunisal—Flushing—Doxorubicin—pancreatic cancer	0.000253	0.00103	CcSEcCtD
Diflunisal—Flatulence—Epirubicin—pancreatic cancer	0.000253	0.00103	CcSEcCtD
Diflunisal—Tension—Epirubicin—pancreatic cancer	0.000252	0.00103	CcSEcCtD
Diflunisal—Nervousness—Epirubicin—pancreatic cancer	0.000249	0.00102	CcSEcCtD
Diflunisal—Muscle spasms—Epirubicin—pancreatic cancer	0.000247	0.00101	CcSEcCtD
Diflunisal—Body temperature increased—Docetaxel—pancreatic cancer	0.000246	0.001	CcSEcCtD
Diflunisal—Vision blurred—Epirubicin—pancreatic cancer	0.000242	0.000988	CcSEcCtD
Diflunisal—Flatulence—Doxorubicin—pancreatic cancer	0.000234	0.000956	CcSEcCtD
Diflunisal—Tension—Doxorubicin—pancreatic cancer	0.000233	0.000952	CcSEcCtD
Diflunisal—Nervousness—Doxorubicin—pancreatic cancer	0.000231	0.000942	CcSEcCtD
Diflunisal—Vertigo—Epirubicin—pancreatic cancer	0.000231	0.000942	CcSEcCtD
Diflunisal—Syncope—Epirubicin—pancreatic cancer	0.00023	0.00094	CcSEcCtD
Diflunisal—Hypersensitivity—Docetaxel—pancreatic cancer	0.000229	0.000934	CcSEcCtD
Diflunisal—Muscle spasms—Doxorubicin—pancreatic cancer	0.000228	0.000932	CcSEcCtD
Diflunisal—Palpitations—Epirubicin—pancreatic cancer	0.000227	0.000926	CcSEcCtD
Diflunisal—Loss of consciousness—Epirubicin—pancreatic cancer	0.000226	0.000921	CcSEcCtD
Diflunisal—Vision blurred—Doxorubicin—pancreatic cancer	0.000224	0.000914	CcSEcCtD
Diflunisal—Asthenia—Docetaxel—pancreatic cancer	0.000223	0.00091	CcSEcCtD
Diflunisal—Pruritus—Docetaxel—pancreatic cancer	0.00022	0.000897	CcSEcCtD
Diflunisal—Chest pain—Epirubicin—pancreatic cancer	0.000219	0.000892	CcSEcCtD
Diflunisal—Vertigo—Doxorubicin—pancreatic cancer	0.000213	0.000871	CcSEcCtD
Diflunisal—Syncope—Doxorubicin—pancreatic cancer	0.000213	0.00087	CcSEcCtD
Diflunisal—Diarrhoea—Docetaxel—pancreatic cancer	0.000213	0.000868	CcSEcCtD
Diflunisal—Confusional state—Epirubicin—pancreatic cancer	0.000211	0.000863	CcSEcCtD
Diflunisal—Palpitations—Doxorubicin—pancreatic cancer	0.00021	0.000857	CcSEcCtD
Diflunisal—Oedema—Epirubicin—pancreatic cancer	0.00021	0.000855	CcSEcCtD
Diflunisal—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00021	0.000855	CcSEcCtD
Diflunisal—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000209	0.000852	CcSEcCtD
Diflunisal—Shock—Epirubicin—pancreatic cancer	0.000206	0.000842	CcSEcCtD
Diflunisal—Dizziness—Docetaxel—pancreatic cancer	0.000205	0.000839	CcSEcCtD
Diflunisal—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000205	0.000838	CcSEcCtD
Diflunisal—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000203	0.000827	CcSEcCtD
Diflunisal—Chest pain—Doxorubicin—pancreatic cancer	0.000202	0.000826	CcSEcCtD
Diflunisal—Anorexia—Epirubicin—pancreatic cancer	0.0002	0.000815	CcSEcCtD
Diflunisal—Vomiting—Docetaxel—pancreatic cancer	0.000198	0.000806	CcSEcCtD
Diflunisal—Rash—Docetaxel—pancreatic cancer	0.000196	0.0008	CcSEcCtD
Diflunisal—Dermatitis—Docetaxel—pancreatic cancer	0.000196	0.000799	CcSEcCtD
Diflunisal—Confusional state—Doxorubicin—pancreatic cancer	0.000196	0.000798	CcSEcCtD
Diflunisal—Headache—Docetaxel—pancreatic cancer	0.000195	0.000794	CcSEcCtD
Diflunisal—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000194	0.000791	CcSEcCtD
Diflunisal—Oedema—Doxorubicin—pancreatic cancer	0.000194	0.000791	CcSEcCtD
Diflunisal—Shock—Doxorubicin—pancreatic cancer	0.000191	0.000779	CcSEcCtD
Diflunisal—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00019	0.000775	CcSEcCtD
Diflunisal—Insomnia—Epirubicin—pancreatic cancer	0.00019	0.000774	CcSEcCtD
Diflunisal—Paraesthesia—Epirubicin—pancreatic cancer	0.000188	0.000768	CcSEcCtD
Diflunisal—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000187	0.000765	CcSEcCtD
Diflunisal—Dyspnoea—Epirubicin—pancreatic cancer	0.000187	0.000763	CcSEcCtD
Diflunisal—Somnolence—Epirubicin—pancreatic cancer	0.000186	0.00076	CcSEcCtD
Diflunisal—Anorexia—Doxorubicin—pancreatic cancer	0.000185	0.000754	CcSEcCtD
Diflunisal—Nausea—Docetaxel—pancreatic cancer	0.000185	0.000753	CcSEcCtD
Diflunisal—Dyspepsia—Epirubicin—pancreatic cancer	0.000185	0.000753	CcSEcCtD
Diflunisal—Decreased appetite—Epirubicin—pancreatic cancer	0.000182	0.000744	CcSEcCtD
Diflunisal—Fatigue—Epirubicin—pancreatic cancer	0.000181	0.000737	CcSEcCtD
Diflunisal—Constipation—Epirubicin—pancreatic cancer	0.000179	0.000731	CcSEcCtD
Diflunisal—Insomnia—Doxorubicin—pancreatic cancer	0.000175	0.000716	CcSEcCtD
Diflunisal—Paraesthesia—Doxorubicin—pancreatic cancer	0.000174	0.000711	CcSEcCtD
Diflunisal—Dyspnoea—Doxorubicin—pancreatic cancer	0.000173	0.000706	CcSEcCtD
Diflunisal—Feeling abnormal—Epirubicin—pancreatic cancer	0.000173	0.000705	CcSEcCtD
Diflunisal—Somnolence—Doxorubicin—pancreatic cancer	0.000172	0.000704	CcSEcCtD
Diflunisal—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000171	0.000699	CcSEcCtD
Diflunisal—Dyspepsia—Doxorubicin—pancreatic cancer	0.000171	0.000697	CcSEcCtD
Diflunisal—Decreased appetite—Doxorubicin—pancreatic cancer	0.000169	0.000688	CcSEcCtD
Diflunisal—Fatigue—Doxorubicin—pancreatic cancer	0.000167	0.000682	CcSEcCtD
Diflunisal—Urticaria—Epirubicin—pancreatic cancer	0.000167	0.00068	CcSEcCtD
Diflunisal—Constipation—Doxorubicin—pancreatic cancer	0.000166	0.000677	CcSEcCtD
Diflunisal—Body temperature increased—Epirubicin—pancreatic cancer	0.000166	0.000676	CcSEcCtD
Diflunisal—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00016	0.000652	CcSEcCtD
Diflunisal—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000159	0.000647	CcSEcCtD
Diflunisal—Hypersensitivity—Epirubicin—pancreatic cancer	0.000154	0.00063	CcSEcCtD
Diflunisal—Urticaria—Doxorubicin—pancreatic cancer	0.000154	0.000629	CcSEcCtD
Diflunisal—Body temperature increased—Doxorubicin—pancreatic cancer	0.000153	0.000626	CcSEcCtD
Diflunisal—Asthenia—Epirubicin—pancreatic cancer	0.00015	0.000614	CcSEcCtD
Diflunisal—Pruritus—Epirubicin—pancreatic cancer	0.000148	0.000605	CcSEcCtD
Diflunisal—Diarrhoea—Epirubicin—pancreatic cancer	0.000143	0.000585	CcSEcCtD
Diflunisal—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000143	0.000583	CcSEcCtD
Diflunisal—Asthenia—Doxorubicin—pancreatic cancer	0.000139	0.000568	CcSEcCtD
Diflunisal—Dizziness—Epirubicin—pancreatic cancer	0.000139	0.000566	CcSEcCtD
Diflunisal—Pruritus—Doxorubicin—pancreatic cancer	0.000137	0.00056	CcSEcCtD
Diflunisal—Vomiting—Epirubicin—pancreatic cancer	0.000133	0.000544	CcSEcCtD
Diflunisal—Diarrhoea—Doxorubicin—pancreatic cancer	0.000133	0.000542	CcSEcCtD
Diflunisal—Rash—Epirubicin—pancreatic cancer	0.000132	0.000539	CcSEcCtD
Diflunisal—Dermatitis—Epirubicin—pancreatic cancer	0.000132	0.000539	CcSEcCtD
Diflunisal—Headache—Epirubicin—pancreatic cancer	0.000131	0.000536	CcSEcCtD
Diflunisal—Dizziness—Doxorubicin—pancreatic cancer	0.000128	0.000523	CcSEcCtD
Diflunisal—Nausea—Epirubicin—pancreatic cancer	0.000125	0.000508	CcSEcCtD
Diflunisal—Vomiting—Doxorubicin—pancreatic cancer	0.000123	0.000503	CcSEcCtD
Diflunisal—Rash—Doxorubicin—pancreatic cancer	0.000122	0.000499	CcSEcCtD
Diflunisal—Dermatitis—Doxorubicin—pancreatic cancer	0.000122	0.000499	CcSEcCtD
Diflunisal—Headache—Doxorubicin—pancreatic cancer	0.000121	0.000496	CcSEcCtD
Diflunisal—Nausea—Doxorubicin—pancreatic cancer	0.000115	0.00047	CcSEcCtD
Diflunisal—PTGS2—C-MYB transcription factor network—MYC—pancreatic cancer	5.45e-05	0.00154	CbGpPWpGaD
Diflunisal—TTR—Disease—SMAD4—pancreatic cancer	5.38e-05	0.00152	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CASP3—pancreatic cancer	5.32e-05	0.00151	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	5.3e-05	0.0015	CbGpPWpGaD
Diflunisal—TTR—Disease—HES1—pancreatic cancer	5.25e-05	0.00149	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CCND1—pancreatic cancer	5.18e-05	0.00147	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SST—pancreatic cancer	5.13e-05	0.00145	CbGpPWpGaD
Diflunisal—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	5.13e-05	0.00145	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	5.07e-05	0.00144	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—APOE—pancreatic cancer	5.05e-05	0.00143	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—KRAS—pancreatic cancer	5.03e-05	0.00143	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MMP9—pancreatic cancer	5.03e-05	0.00142	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—JAG1—pancreatic cancer	5.02e-05	0.00142	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NOTCH3—pancreatic cancer	5e-05	0.00142	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—VEGFA—pancreatic cancer	4.98e-05	0.00141	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TNF—pancreatic cancer	4.98e-05	0.00141	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—TNF—pancreatic cancer	4.89e-05	0.00139	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PRSS1—pancreatic cancer	4.78e-05	0.00136	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	4.75e-05	0.00134	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CNR1—pancreatic cancer	4.74e-05	0.00134	CbGpPWpGaD
Diflunisal—TTR—Disease—TERT—pancreatic cancer	4.6e-05	0.0013	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GCG—pancreatic cancer	4.58e-05	0.0013	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—TGFB1—pancreatic cancer	4.57e-05	0.0013	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CG—pancreatic cancer	4.56e-05	0.00129	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PRSS1—pancreatic cancer	4.53e-05	0.00128	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ZNRF3—pancreatic cancer	4.53e-05	0.00128	CbGpPWpGaD
Diflunisal—TTR—Disease—HIF1A—pancreatic cancer	4.4e-05	0.00125	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PPARG—pancreatic cancer	4.4e-05	0.00125	CbGpPWpGaD
Diflunisal—TTR—Disease—TSC2—pancreatic cancer	4.39e-05	0.00124	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TP53—pancreatic cancer	4.39e-05	0.00124	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AGTR1—pancreatic cancer	4.37e-05	0.00124	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	4.36e-05	0.00123	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—STK11—pancreatic cancer	4.3e-05	0.00122	CbGpPWpGaD
Diflunisal—TTR—Disease—APOE—pancreatic cancer	4.3e-05	0.00122	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—HRAS—pancreatic cancer	4.28e-05	0.00121	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MYC—pancreatic cancer	4.15e-05	0.00118	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ARG2—pancreatic cancer	4.15e-05	0.00117	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TGFB1—pancreatic cancer	4.14e-05	0.00117	CbGpPWpGaD
Diflunisal—PTGS2—Disease—DTX1—pancreatic cancer	4.1e-05	0.00116	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—EGFR—pancreatic cancer	4.06e-05	0.00115	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CD—pancreatic cancer	4.01e-05	0.00114	CbGpPWpGaD
Diflunisal—TTR—Disease—NOTCH1—pancreatic cancer	3.97e-05	0.00112	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	3.96e-05	0.00112	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TNF—pancreatic cancer	3.87e-05	0.0011	CbGpPWpGaD
Diflunisal—TTR—Disease—EGF—pancreatic cancer	3.83e-05	0.00109	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PRSS1—pancreatic cancer	3.8e-05	0.00108	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SMAD4—pancreatic cancer	3.77e-05	0.00107	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.74e-05	0.00106	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	3.7e-05	0.00105	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HES1—pancreatic cancer	3.68e-05	0.00104	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	3.65e-05	0.00103	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TYMP—pancreatic cancer	3.63e-05	0.00103	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	3.62e-05	0.00102	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.52e-05	0.000997	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CB—pancreatic cancer	3.49e-05	0.00099	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.49e-05	0.000988	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTGS2—pancreatic cancer	3.46e-05	0.000981	CbGpPWpGaD
Diflunisal—PTGS2—Disease—DTX4—pancreatic cancer	3.44e-05	0.000974	CbGpPWpGaD
Diflunisal—TTR—Disease—PIK3CD—pancreatic cancer	3.41e-05	0.000966	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TP53—pancreatic cancer	3.41e-05	0.000966	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3.4e-05	0.000963	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CD44—pancreatic cancer	3.35e-05	0.000948	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PPP2R5B—pancreatic cancer	3.34e-05	0.000947	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ARG2—pancreatic cancer	3.29e-05	0.000933	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	3.25e-05	0.00092	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IFNA1—pancreatic cancer	3.24e-05	0.000918	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TERT—pancreatic cancer	3.22e-05	0.000913	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HEY2—pancreatic cancer	3.22e-05	0.000912	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	3.15e-05	0.000893	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HIF1A—pancreatic cancer	3.08e-05	0.000874	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TSC2—pancreatic cancer	3.08e-05	0.000871	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PRSS1—pancreatic cancer	3.07e-05	0.00087	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	3.07e-05	0.00087	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTEN—pancreatic cancer	3.02e-05	0.000855	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IFNA2—pancreatic cancer	3.02e-05	0.000855	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—APOE—pancreatic cancer	3.01e-05	0.000853	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.99e-05	0.000847	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HEY1—pancreatic cancer	2.98e-05	0.000844	CbGpPWpGaD
Diflunisal—TTR—Disease—PIK3CB—pancreatic cancer	2.97e-05	0.000842	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KDR—pancreatic cancer	2.95e-05	0.000835	CbGpPWpGaD
Diflunisal—TTR—Disease—PTGS2—pancreatic cancer	2.95e-05	0.000834	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GLP1R—pancreatic cancer	2.92e-05	0.000828	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TYMP—pancreatic cancer	2.88e-05	0.000815	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—DPYD—pancreatic cancer	2.87e-05	0.000814	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	2.83e-05	0.000802	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.82e-05	0.0008	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.82e-05	0.000798	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NFKBIA—pancreatic cancer	2.8e-05	0.000795	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NOTCH1—pancreatic cancer	2.78e-05	0.000787	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.76e-05	0.000783	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SLC2A2—pancreatic cancer	2.73e-05	0.000773	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CG—pancreatic cancer	2.72e-05	0.00077	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.7e-05	0.000765	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EGF—pancreatic cancer	2.69e-05	0.000761	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ARG2—pancreatic cancer	2.66e-05	0.000755	CbGpPWpGaD
Diflunisal—PTGS2—Disease—JAG2—pancreatic cancer	2.64e-05	0.000749	CbGpPWpGaD
Diflunisal—TTR—Disease—CTNNB1—pancreatic cancer	2.64e-05	0.000747	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.63e-05	0.000745	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.61e-05	0.000739	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.61e-05	0.000738	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MEN1—pancreatic cancer	2.6e-05	0.000738	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SLC2A2—pancreatic cancer	2.59e-05	0.000733	CbGpPWpGaD
Diflunisal—TTR—Disease—PTEN—pancreatic cancer	2.57e-05	0.000728	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SHH—pancreatic cancer	2.48e-05	0.000704	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IAPP—pancreatic cancer	2.45e-05	0.000695	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.4e-05	0.000679	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CD—pancreatic cancer	2.39e-05	0.000677	CbGpPWpGaD
Diflunisal—TTR—Disease—SRC—pancreatic cancer	2.38e-05	0.000675	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.37e-05	0.000673	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.37e-05	0.000672	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HSPA1B—pancreatic cancer	2.36e-05	0.000667	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TYMP—pancreatic cancer	2.33e-05	0.00066	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GLP1R—pancreatic cancer	2.32e-05	0.000657	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.32e-05	0.000657	CbGpPWpGaD
Diflunisal—TTR—Disease—STAT3—pancreatic cancer	2.3e-05	0.000651	CbGpPWpGaD
Diflunisal—TTR—Disease—NRAS—pancreatic cancer	2.29e-05	0.000649	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—DPYD—pancreatic cancer	2.28e-05	0.000647	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	2.27e-05	0.000643	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	2.21e-05	0.000626	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC2A2—pancreatic cancer	2.17e-05	0.000614	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.14e-05	0.000607	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PLAU—pancreatic cancer	2.14e-05	0.000606	CbGpPWpGaD
Diflunisal—TTR—Disease—MYC—pancreatic cancer	2.13e-05	0.000605	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CA—pancreatic cancer	2.13e-05	0.000603	CbGpPWpGaD
Diflunisal—TTR—Disease—TGFB1—pancreatic cancer	2.13e-05	0.000603	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CD44—pancreatic cancer	2.11e-05	0.000599	CbGpPWpGaD
Diflunisal—PTGS2—Disease—JAG1—pancreatic cancer	2.11e-05	0.000597	CbGpPWpGaD
Diflunisal—TTR—Disease—EGFR—pancreatic cancer	2.09e-05	0.000591	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CB—pancreatic cancer	2.08e-05	0.00059	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.07e-05	0.000586	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.07e-05	0.000586	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.05e-05	0.000581	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	2.03e-05	0.000575	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GCG—pancreatic cancer	2.03e-05	0.000574	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD44—pancreatic cancer	2e-05	0.000567	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCL8—pancreatic cancer	2e-05	0.000567	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HSPA1A—pancreatic cancer	1.99e-05	0.000563	CbGpPWpGaD
Diflunisal—TTR—Disease—KRAS—pancreatic cancer	1.97e-05	0.000559	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.96e-05	0.000555	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.92e-05	0.000544	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CASP3—pancreatic cancer	1.91e-05	0.000542	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CG—pancreatic cancer	1.9e-05	0.00054	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—STK11—pancreatic cancer	1.9e-05	0.000539	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.88e-05	0.000534	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—EGF—pancreatic cancer	1.88e-05	0.000533	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GLP1R—pancreatic cancer	1.88e-05	0.000532	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCND1—pancreatic cancer	1.86e-05	0.000528	CbGpPWpGaD
Diflunisal—ALB—Metabolism—DPYD—pancreatic cancer	1.85e-05	0.000523	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CTNNB1—pancreatic cancer	1.85e-05	0.000523	CbGpPWpGaD
Diflunisal—TTR—Disease—PIK3CA—pancreatic cancer	1.81e-05	0.000513	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MMP9—pancreatic cancer	1.81e-05	0.000513	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTEN—pancreatic cancer	1.8e-05	0.00051	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.79e-05	0.000506	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC2A2—pancreatic cancer	1.75e-05	0.000496	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—AKT1—pancreatic cancer	1.74e-05	0.000493	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.73e-05	0.000491	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	1.73e-05	0.000489	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CD44—pancreatic cancer	1.68e-05	0.000475	CbGpPWpGaD
Diflunisal—TTR—Disease—HRAS—pancreatic cancer	1.68e-05	0.000475	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CD—pancreatic cancer	1.67e-05	0.000474	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.67e-05	0.000474	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SRC—pancreatic cancer	1.67e-05	0.000473	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.64e-05	0.000465	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TYMS—pancreatic cancer	1.64e-05	0.000464	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VEGFA—pancreatic cancer	1.62e-05	0.00046	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—STAT3—pancreatic cancer	1.61e-05	0.000456	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GCG—pancreatic cancer	1.61e-05	0.000456	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NRAS—pancreatic cancer	1.6e-05	0.000455	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SMAD4—pancreatic cancer	1.58e-05	0.000448	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HES1—pancreatic cancer	1.54e-05	0.000437	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.52e-05	0.000432	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—STK11—pancreatic cancer	1.51e-05	0.000428	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MYC—pancreatic cancer	1.49e-05	0.000423	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TGFB1—pancreatic cancer	1.49e-05	0.000422	CbGpPWpGaD
Diflunisal—TTR—Disease—AKT1—pancreatic cancer	1.48e-05	0.000419	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EGFR—pancreatic cancer	1.46e-05	0.000414	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CB—pancreatic cancer	1.46e-05	0.000413	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.42e-05	0.000402	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	1.41e-05	0.000399	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KRAS—pancreatic cancer	1.38e-05	0.000391	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CD44—pancreatic cancer	1.36e-05	0.000384	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TERT—pancreatic cancer	1.35e-05	0.000383	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—APOE—pancreatic cancer	1.33e-05	0.000377	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.33e-05	0.000376	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.32e-05	0.000373	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GCG—pancreatic cancer	1.3e-05	0.000369	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TYMS—pancreatic cancer	1.3e-05	0.000368	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HIF1A—pancreatic cancer	1.29e-05	0.000366	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TSC2—pancreatic cancer	1.29e-05	0.000366	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CA—pancreatic cancer	1.27e-05	0.000359	CbGpPWpGaD
Diflunisal—PTGS2—Disease—APOE—pancreatic cancer	1.26e-05	0.000358	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.26e-05	0.000357	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TP53—pancreatic cancer	1.23e-05	0.000348	CbGpPWpGaD
Diflunisal—ALB—Metabolism—STK11—pancreatic cancer	1.22e-05	0.000346	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CG—pancreatic cancer	1.2e-05	0.000341	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HRAS—pancreatic cancer	1.17e-05	0.000333	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SRC—pancreatic cancer	1.17e-05	0.000331	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NOTCH1—pancreatic cancer	1.17e-05	0.00033	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PPARG—pancreatic cancer	1.16e-05	0.000329	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.15e-05	0.000325	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VEGFA—pancreatic cancer	1.14e-05	0.000323	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGF—pancreatic cancer	1.13e-05	0.000319	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—NRAS—pancreatic cancer	1.13e-05	0.000319	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—APOE—pancreatic cancer	1.06e-05	0.0003	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CD—pancreatic cancer	1.06e-05	0.000299	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TYMS—pancreatic cancer	1.05e-05	0.000298	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TGFB1—pancreatic cancer	1.05e-05	0.000296	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AKT1—pancreatic cancer	1.04e-05	0.000294	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CD—pancreatic cancer	1e-05	0.000284	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1e-05	0.000284	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—KRAS—pancreatic cancer	9.68e-06	0.000274	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CG—pancreatic cancer	9.55e-06	0.00027	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CB—pancreatic cancer	9.21e-06	0.000261	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PPARG—pancreatic cancer	9.21e-06	0.000261	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTGS2—pancreatic cancer	9.13e-06	0.000259	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CA—pancreatic cancer	8.9e-06	0.000252	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CB—pancreatic cancer	8.73e-06	0.000247	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TP53—pancreatic cancer	8.61e-06	0.000244	CbGpPWpGaD
Diflunisal—ALB—Metabolism—APOE—pancreatic cancer	8.56e-06	0.000242	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CD—pancreatic cancer	8.39e-06	0.000238	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—HRAS—pancreatic cancer	8.23e-06	0.000233	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.1e-06	0.000229	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTEN—pancreatic cancer	7.96e-06	0.000226	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CTNNB1—pancreatic cancer	7.74e-06	0.000219	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CG—pancreatic cancer	7.72e-06	0.000219	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PTEN—pancreatic cancer	7.55e-06	0.000214	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PPARG—pancreatic cancer	7.45e-06	0.000211	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CB—pancreatic cancer	7.31e-06	0.000207	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—AKT1—pancreatic cancer	7.27e-06	0.000206	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SRC—pancreatic cancer	7e-06	0.000198	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CD—pancreatic cancer	6.79e-06	0.000192	CbGpPWpGaD
Diflunisal—PTGS2—Disease—STAT3—pancreatic cancer	6.75e-06	0.000191	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NRAS—pancreatic cancer	6.73e-06	0.000191	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PTEN—pancreatic cancer	6.32e-06	0.000179	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MYC—pancreatic cancer	6.27e-06	0.000178	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TGFB1—pancreatic cancer	6.26e-06	0.000177	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGFR—pancreatic cancer	6.13e-06	0.000174	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CB—pancreatic cancer	5.92e-06	0.000168	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS2—pancreatic cancer	5.86e-06	0.000166	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KRAS—pancreatic cancer	5.79e-06	0.000164	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CA—pancreatic cancer	5.62e-06	0.000159	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CA—pancreatic cancer	5.32e-06	0.000151	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTEN—pancreatic cancer	5.11e-06	0.000145	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HRAS—pancreatic cancer	4.93e-06	0.00014	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—AKT1—pancreatic cancer	4.59e-06	0.00013	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CA—pancreatic cancer	4.46e-06	0.000126	CbGpPWpGaD
Diflunisal—PTGS2—Disease—AKT1—pancreatic cancer	4.35e-06	0.000123	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—AKT1—pancreatic cancer	3.64e-06	0.000103	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CA—pancreatic cancer	3.61e-06	0.000102	CbGpPWpGaD
Diflunisal—ALB—Metabolism—AKT1—pancreatic cancer	2.95e-06	8.35e-05	CbGpPWpGaD
